Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Breast Cancer Liquid Biopsy Testing Devices Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of breast cancer among women worldwide
5.1.1.2. Increasing demand for non-invasive breast cancer treatment
5.1.1.3. Surge in pre-screening programs for breast cancer detection
5.1.2. Restraints
5.1.2.1. Concerns related to the accuracy of testing devices
5.1.3. Opportunities
5.1.3.1. Technological advancements in breast cancer liquid biopsy testing devices
5.1.3.2. Investments in R&D for breast cancer testing
5.1.4. Challenges
5.1.4.1. Presence of strict standards for liquid biopsy
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Breast Cancer Liquid Biopsy Testing Devices Market, by Offerings
6.1. Introduction
6.2. Assay & Reagents Kits
6.3. Instruments

7. Breast Cancer Liquid Biopsy Testing Devices Market, by Circulating Biomarker
7.1. Introduction
7.2. Circulating Tumar DNA
7.3. Circulating Tumor Cell
7.4. Extracellular Vesicles

8. Breast Cancer Liquid Biopsy Testing Devices Market, by End-User
8.1. Introduction
8.2. Hospitals
8.3. Research Laboratories

9. Breast Cancer Liquid Biopsy Testing Devices Market, by Appplication
9.1. Introduction
9.2. Diagnosis
9.3. Monitoring
9.4. Screening/Early Detection
9.5. Treatment Selection

10. Americas Breast Cancer Liquid Biopsy Testing Devices Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Breast Cancer Liquid Biopsy Testing Devices Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Breast Cancer Liquid Biopsy Testing Devices Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Agilent Technologies, Inc.
14.1.2. Becton, Dickinson and Company
14.1.3. Bio-Rad Laboratories, Inc.
14.1.4. Biocept, Inc.
14.1.5. Biodesix, Inc.
14.1.6. BioVIew Ltd.
14.1.7. Eurofins Scientific SE
14.1.8. Exact Sciences Corporation
14.1.9. F. Hoffmann-La Roche AG
14.1.10. Fluxion Biosciences Inc.
14.1.11. Guardant Health, Inc.
14.1.12. Illumina, Inc.
14.1.13. Isogen Life Science B.V.
14.1.14. Johnson & Johnson Services, Inc.
14.1.15. Laboratory Corporation of America Holdings
14.1.16. Lucence Health Inc.
14.1.17. Menarini Group
14.1.18. Merck KGaA
14.1.19. Myriad Genetics, Inc.
14.1.20. Natera Inc.
14.1.21. Neogenomics Laboratories, Inc.
14.1.22. OncoDNA SA
14.1.23. Qiagen N.V.
14.1.24. Sysmex Corporation
14.1.25. Thermo Fisher Scientific Inc.
14.2. Key Product Portfolio

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing



List of Figures

FIGURE 1. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET RESEARCH PROCESS
FIGURE 2. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET DYNAMICS
FIGURE 7. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2023 VS 2030 (%)
FIGURE 8. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2023 VS 2030 (%)
FIGURE 10. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2023 VS 2030 (%)
FIGURE 14. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 6. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY ASSAY & REAGENTS KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 9. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING TUMAR DNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING TUMOR CELL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY EXTRACELLULAR VESICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 13. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 16. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY SCREENING/EARLY DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY TREATMENT SELECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 33. CANADA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 34. CANADA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 35. CANADA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. CANADA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 37. MEXICO BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 38. MEXICO BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 39. MEXICO BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. MEXICO BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 55. CHINA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 56. CHINA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 57. CHINA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. CHINA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 59. INDIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 60. INDIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 61. INDIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. INDIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 67. JAPAN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 68. JAPAN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 69. JAPAN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. JAPAN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 91. THAILAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 92. THAILAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 93. THAILAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. THAILAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. DENMARK BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 105. DENMARK BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 106. DENMARK BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. DENMARK BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 108. EGYPT BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 109. EGYPT BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 110. EGYPT BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. EGYPT BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 112. FINLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 113. FINLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 114. FINLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. FINLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 116. FRANCE BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 117. FRANCE BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 118. FRANCE BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. FRANCE BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 120. GERMANY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 121. GERMANY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 122. GERMANY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. GERMANY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 128. ITALY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 129. ITALY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 130. ITALY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. ITALY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 140. NORWAY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 141. NORWAY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 142. NORWAY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. NORWAY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 144. POLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 145. POLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 146. POLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. POLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 148. QATAR BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 149. QATAR BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 150. QATAR BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. QATAR BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 164. SPAIN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 165. SPAIN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 166. SPAIN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. SPAIN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 176. TURKEY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 177. TURKEY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 178. TURKEY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. TURKEY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPPLICATION, 2018-2030 (USD MILLION)
TABLE 188. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 189. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 190. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET LICENSE & PRICING